Sign in
4

Changes in Ownership

Lineage Cell Therapeutics, Inc. Filed Acc 0001493152-19-014109

10% owner sold 4,000,000 shares at $1.66 ($6,640,000)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Lineage Cell Therapeutics, Inc. 10% owner 2019-09-11 Sale −4,000,000 $1.66 $6,640,000 8,424,244 D: show line 1 in the form
Open-market sales · 4,000,000 sh · avg $1.66 · $6,640,000
Loading xslF345X03/ownership.xml…